(Q38000088)

26 August 2017

Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence (English)

1 reference

26 August 2017

0 references

D Witte

3

0 references

author name string

J A Johnson

1

1 reference

26 August 2017

B Carstensen

2

1 reference

26 August 2017

S L Bowker

4

1 reference

26 August 2017

L Lipscombe

5

1 reference

26 August 2017

A G Renehan

6

1 reference

26 August 2017

Diabetes and Cancer Research Consortium

7

1 reference

26 August 2017

4 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

55

1 reference

26 August 2017

6

1 reference

26 August 2017

1607-1618

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-012-2525-1

26 August 2017

0 references

cites work

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

1 reference

12 December 2020

Diabetes mellitus and risk of colorectal cancer: a meta-analysis

1 reference

12 December 2020

Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study.

1 reference

12 December 2020

Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients

1 reference

12 December 2020

Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias.

1 reference

12 December 2020

Diabetes mellitus and ovarian cancer (Sweden).

1 reference

12 December 2020

Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

1 reference

12 December 2020

Metformin, cancer, alphabet soup, and the role of epidemiology in etiologic research

1 reference

12 December 2020

Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies

1 reference

12 December 2020

Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.

1 reference

12 December 2020

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

1 reference

12 December 2020

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical t

1 reference

12 December 2020

Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.

1 reference

12 December 2020

Assessment and control for confounding by indication in observational studies.

1 reference

12 December 2020

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

1 reference

12 December 2020

Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials

1 reference

12 December 2020

Insulin glargine and cancer--an unsubstantiated allegation

1 reference

12 December 2020

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

1 reference

12 December 2020

A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer

1 reference

12 December 2020

Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase

1 reference

12 December 2020

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Diabetes and the risk of lung cancer

1 reference

12 December 2020

Epidemiological aspects of neoplasms in diabetes

1 reference

12 December 2020

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden

1 reference

12 December 2020

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

1 reference

12 December 2020

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

1 reference

12 December 2020

Obesity and cancer: the role of dysfunctional adipose tissue

1 reference

12 December 2020

Hallmarks of Cancer: The Next Generation

1 reference

12 December 2020

Diabetes mellitus and risk of breast cancer: a meta-analysis

1 reference

12 December 2020

Diabetes mellitus and risk of bladder cancer: a meta-analysis

1 reference

12 December 2020

Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview

1 reference

12 December 2020

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

1 reference

12 December 2020

Does insulin therapy promote, reduce, or have a neutral effect on cancers?

1 reference

12 December 2020

Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients

1 reference

12 December 2020

Fasting serum glucose level and cancer risk in Korean men and women

1 reference

12 December 2020

Immortal time bias in pharmaco-epidemiology

1 reference

12 December 2020

Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study

1 reference

12 December 2020

Insulin and insulin-like growth factor signalling in neoplasia

1 reference

12 December 2020

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

1 reference

12 December 2020

Insulin glargine and cancer: another side to the story?

1 reference

12 December 2020

Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

1 reference

12 December 2020

Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study.

1 reference

12 December 2020

Impact of fasting plasma glucose levels on gastric cancer incidence in a general Japanese population: the Hisayama study

1 reference

12 December 2020

Why do people with diabetes die too soon? More questions than answers

1 reference

12 December 2020

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

1 reference

12 December 2020

Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies

1 reference

12 December 2020

Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations

1 reference

12 December 2020

Diabetes mellitus, fasting glucose, and risk of cause-specific death

1 reference

12 December 2020

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

12 December 2020

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

1 reference

12 December 2020

Cancer and diabetes--a follow-up study of two population-based cohorts of diabetic patients

1 reference

12 December 2020

Bariatric surgery, weight reduction, and cancer prevention

1 reference

12 December 2020

No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis

1 reference

12 December 2020

Glycemic index, glycemic load, and chronic disease risk--a meta-analysis of observational studies

1 reference

12 December 2020

Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects

1 reference

12 December 2020

The American Cancer Society, American Diabetes Association, and American Heart Association joint statement on preventing cancer, cardiovascular disease, and diabetes: where are the social determinants?

1 reference

12 December 2020

Why drug safety should not take a back seat to efficacy

1 reference

12 December 2020

Tobacco smoking and cancer: a brief review of recent epidemiological evidence

1 reference

12 December 2020

Diabetes and risk of Non-Hodgkin's lymphoma: a meta-analysis of observational studies

1 reference

12 December 2020

Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer

1 reference

12 December 2020

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

1 reference

12 December 2020

Diabetes mellitus and risk of endometrial cancer: a meta-analysis

1 reference

12 December 2020

Colorectal cancer incidence trends in the United States and United kingdom: evidence of right- to left-sided biological gradients with implications for screening

1 reference

12 December 2020

A meta-analysis of diabetes mellitus and the risk of prostate cancer

1 reference

12 December 2020

Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes

1 reference

12 December 2020

Do cancer cells care if their host is hungry?

1 reference

12 December 2020

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

1 reference

12 December 2020

Metformin and reduced risk of cancer in diabetic patients

1 reference

12 December 2020

1 reference

12 December 2020

Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC).

1 reference

12 December 2020

Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan

1 reference

12 December 2020

Insulin glargine and malignancy: an unwarranted alarm

1 reference

12 December 2020

Effects of exercise modality on insulin resistance and functional limitation in older adults: a randomized controlled trial.

1 reference

12 December 2020

Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies

1 reference

12 December 2020

Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts

1 reference

12 December 2020

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

12 December 2020

Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem?

1 reference

12 December 2020

Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study

1 reference

12 December 2020

Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions?

1 reference

12 December 2020

Diabetes and cancer: a consensus report.

1 reference

12 December 2020

Does diabetes therapy influence the risk of cancer?

1 reference

12 December 2020

Influence of glucose concentration on growth and formation of necrosis in spheroids derived from a human bladder cancer cell line

1 reference

12 December 2020

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

1 reference

12 December 2020

Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden

1 reference

12 December 2020

10.1007/S00125-012-2525-1

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

0 references

1 reference